News Center
Excellent! Lijuzhu Group has passed this evaluation by the National Development and Reform Commission!
Release time:
2022-02-16
Recently, the General Office of the National Development and Reform Commission announced the evaluation results of the National Enterprise Technology Center for 2021. 72 enterprise technology centers scored above 90 points and were approved as excellent. Livzon Group successfully passed the evaluation with a score of 90.3.
The National Enterprise Technology Center refers to a technology center recognized by the National Development and Reform Commission, which has strong technological innovation capabilities, leading research and development and innovation levels in the same industry, possesses core technologies with independent intellectual property rights, and has international competitiveness. Its qualifications are jointly granted by five ministries: the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Finance, the General Administration of Customs, and the State Administration of Taxation. The certification and review process is strict, and the evaluation results are authoritative, making it one of the highest specifications and most influential technology innovation platforms in the country.
Livzon Group has always adhered to research and development innovation, possessing national-level R&D platforms such as the "National Modernization Engineering Technology Research Center for Traditional Chinese Medicine" and the "National and Local Joint Engineering Research Center for Long-acting Microsphere Technology," as well as eight provincial-level R&D platforms including the "Guangdong Provincial Digital Traditional Chinese Medicine Engineering Technology Research and Development Center," "Guangdong Provincial Livzon Pharmaceutical Key Engineering Technology Research and Development Center," "Guangdong Provincial Livzon In Vitro Diagnostic Engineering Technology Research and Development Center," "Guangdong Provincial Cephalosporin Drug Engineering Technology Research Center," and "Guangdong Provincial Fermentation Pharmaceutical Engineering Technology Research and Development Center." The products Shenqi Fuzheng Injection and Aprepitant have successively won the first prize for scientific and technological progress in Guangdong Province and the second prize for national scientific and technological progress.
In recent years, Livzon Group has continuously made breakthroughs in the fields of chemical drugs, traditional Chinese medicine, biological drugs, raw materials, and in vitro diagnostic reagents, consistently focusing on innovative drug main business and high-barrier complex formulations, launching heavyweight products such as Leuprolide, and promoting the steady development of the company.
Livzon Group has been recognized as a National Enterprise Technology Center since 2009. This time, passing the evaluation as excellent is a high recognition of Livzon Group's persistent commitment to research and development innovation, as well as a comprehensive assessment of Livzon Group's operational achievements in the past two years. Livzon Group will continue to drive development through research and development innovation, making new and greater contributions to the health industry!
Related Information